NCT02797886

Brief Summary

The goal of the study is to explore the effect of combined training involving functional electrical stimulation (FES) of the ankle dorsal flexor with simultaneous maximal-effort voluntary contraction of the same muscle to correct or improve foot drop in chronic stroke patients. Participants will be assessed for functional motor ability and neurological function during their first visit and then again after five and then ten weeks of training. Functional motor ability is broken down into dorsiflexion strength and general gait analysis. Dorsiflexion strength is measured by use of a dynamometer. Gait is assessed via recordings of electromyography, pedobarography, kinematic, and various functional variables during 10 walking trials. The neurological assessment will include electroencephalographic (EEG) analysis of movement-related cortical potentials (MRCP), somatosensory evoked potentials (SSEP), and M-wave response to stimulation. Participants will be randomly assigned to one of three groups: 1) FES + volitional movement (VOL), 2) FES alone, and 3) VOL alone, which will determine their training regimen. The training sessions involve roughly 20 minutes of repeated muscle contractions (with appropriate breaks to avoid fatigue). The participants assigned to the FES+VOL group will receive electrical stimulation to the peroneal nerve in concert with volitional dorsiflexion, whereas the other groups will either dorsiflex voluntarily with no stimulation or receive stimulation while being asked to do nothing.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for not_applicable stroke

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 14, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Last Updated

June 14, 2016

Status Verified

June 1, 2016

Enrollment Period

1 year

First QC Date

May 31, 2016

Last Update Submit

June 8, 2016

Conditions

Keywords

HemiplegiaDrop footFoot drop

Outcome Measures

Primary Outcomes (7)

  • Force Produced by Voluntary Dorsiflexion

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

  • Time to Complete 10 Meter Walk

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

  • Center of Pressure of Plantar Loading During Walking Trial

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

  • Joint Angles During Walking Trial

    Sagittal (flexion and extension), frontal (abduction and adduction) and transverse (internal and external rotation) plane angles of the ankle, knee, and hip.

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

  • Amplitude of the Major Components of Somatosensory Evoked Potentials

    Amplitude of the N1, N2, P1, and P2 components of artifact free epochs

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

  • Amplitude of the P40-N50 Complex During Movement Related Cortical Potentials

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

  • Amplitude and Latency of M-Wave Component of EMG During Maximal Voluntary Contraction

    Change from baseline to 0 weeks post-intervention and from baseline to 5 weeks post-intervention

Study Arms (3)

FES+VOL

EXPERIMENTAL

Electrical stimulation (FES) in concert with volitional effort. The subject is visually cued to initiate the movement and when they begin the movement (as ascertained by EMG response), the stimulation is immediately applied until the completion of the trial.

Other: FES + VOL

FES

ACTIVE COMPARATOR

Electrical stimulation alone. The subject is asked to do nothing as electrical stimulation initiates and completes the movement for them.

Other: FES

VOL

ACTIVE COMPARATOR

Volitional effort alone. When cued, the subject initiates and completes the movement on their own until the completion of the trial. There is no electrical stimulation in this group.

Other: VOL

Interventions

Electrical stimulation is applied in concert with the subject's volitional movement.

FES+VOL
FESOTHER

Electrical stimulation is applied to the subject while they are asked to do nothing.

FES
VOLOTHER

The subject initiates and completes the movement without electrical stimulation.

VOL

Eligibility Criteria

Age10 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Must be hemiplegic secondary to stroke and exhibit foot drop (as diagnosed by the participant's treating physician)
  • Between the ages of 10 and 90.
  • Must have sustained a stroke at least 6 months prior to enrollment.
  • Uninvolved lower limb must have no history of injury or pathology within the last 90 days.
  • Must be able to walk independently for 10 meters.
  • Must have inadequate dorsiflexion during the swing phase of gait resulting in inadequate limb clearance
  • Medically stable for three months prior to the most recent episode of stroke resulting in hemiplegia or hemiparesis with foot drop
  • Adequate cognitive function to give informed consent, understand instructions, and give adequate feedback.

You may not qualify if:

  • Individuals with additional orthopedic, neuromuscular, or neurological pathologies that would interfere with their ability to walk
  • Individuals with previous use of FES for community ambulation (neuroprosthesis) or clinical treatment \<1 year will be excluded from participation due to possible confounding effects
  • Severe cardiac disease such as myocardial infarction, or congestive heart failure
  • Fixed ankle contractures of ten degrees of plantarflexion with knee extended
  • Pre-existing pathology resulting in a significant disruption in alignment or function of the lower extremity
  • Excessive dysesthetic pain secondary to neurological involvement
  • Severe hypertonicity resulting in the need for more involved rehabilitation strategies
  • Participants will not be excluded due to gender or ethnicity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokePeroneal NeuropathiesHemiplegia

Interventions

proto-oncogene protein c-fes-fps

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2016

First Posted

June 14, 2016

Study Start

June 1, 2016

Primary Completion

June 1, 2017

Last Updated

June 14, 2016

Record last verified: 2016-06